ABSTRACT
The
NR2E3
R311Q
mutation
can
lead
to
retinitis
pigmentosa,
enhanced
S‐cone
syndrome
(ESCS),
Goldmann–Favre
syndrome,
and
clumped
pigmentary
retinal
degeneration.
relationship
between
this
various
recessive
inherited
degenerative
disorders
is
unclear
complicates
clinical
diagnosis
treatment.
In
study,
we
generated
a
mouse
strain
carrying
the
R296Q
using
CRISPR/Cas9
technology
simulate
in
humans
investigate
influence
of
missense
on
photoreceptor
developmental
profile
maintenance.
Retinal
architecture
lamination
were
normal
mice.
Whorls
rosettes
not
observed
outer
nuclear
layer
(ONL).
Rod
cell
quantity
developed
normally,
whereas
small
amount
Rhodopsin
was
incorrectly
located
ONL.
Blue
cones
excessively
produced
at
dorsal
retina,
green
cone
development
normal.
Colocalization
Arrestin
occurred
retinas
Heterozygous
+/R296Q
mice
showed
no
evident
abnormalities
structure
or
development.
Retinas
underwent
progressive
degeneration
starting
early
postnatal
stage,
which
manifested
as
reduced
ONL
thickness
segment
fragmentation.
where
redundant
blue
are
generated,
degenerated
more
advanced
manner.
At
molecular
level,
bound
directly
RXRG
promoter,
significantly
impaired
binding,
resulting
decreased
mRNA
protein
expressions.
summary,
novel
model
exhibiting
an
ESCS‐like
phenotype,
thus
providing
NR2E3‐RXRG
signaling
pathway
for
modulating
Naunyn-Schmiedeberg s Archives of Pharmacology,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 15, 2025
Abstract
Diabetic
retinopathy
(DR)
represents
a
significant
and
serious
complication
associated
with
diabetes
mellitus
(DM),
often
resulting
in
considerable
visual
impairment
or
even
blindness.
The
intricate
pathological
processes
underlying
DR
complicate
the
effectiveness
of
current
treatment
modalities.
Studies
have
highlighted
potential
natural
products
via
several
beneficial
effects
including
anti-inflammatory,
antioxidant,
anti-neovascular,
anti-apoptotic
properties.
Flavonoids,
saponins,
saccharides,
alkaloids
exhibited
various
vivo
vitro
studies.
However,
clinical
utilization
these
compounds
is
hindered
by
issues
such
as
inadequate
specificity,
low
bioavailability,
toxicity.
Therefore,
there
pressing
need
for
rigorous
studies
to
confirm
efficacy
preventing
mitigating
progression
DR.
Clinical and Experimental Ophthalmology,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 27, 2025
Phototransduction,
the
process
by
which
captured
photons
elicit
electrical
changes
in
retinal
rod
and
cone
cells,
represents
first
neuronal
step
vision
involves
interactions
between
several
highly
specialised
proteins.
Pathogenic
variants
genes
encoding
many
of
these
proteins
can
give
rise
to
significant
impairment,
accounting
for
a
substantial
portion
inherited
disease.
Such
include
RHO,
OPN1LW,
OPN1MW,
GNAT1,
GNAT2,
GNB3,
PDE6A,
PDE6B,
PDE6G,
PDE6C,
PDE6H,
CNGA1,
CNGB1,
CNGA3,
CNGB3,
GRK1,
SAG,
ARR3,
RGS9,
RGS9BP,
GUCY2D,
GUCA1A
SLC24A1.
Many
conditions
have
distinct
mechanisms
clinical
features.
They
follow
modes
inheritance
(including
one
case
digenic,
or
tri-allelic,
inheritance).
Some
also
entail
myopia.
Rod
phototransduction
will
be
outlined,
followed
discussion
diseases
associated
with
genes.
phenotypic
features
highlighted
as
well
their
prevalence
large
genotyped
disease
cohort.
Nature Communications,
Год журнала:
2025,
Номер
16(1)
Опубликована: Март 10, 2025
The
next-generation
gene
editing
tool,
prime
(PE),
is
adept
at
correcting
point
mutations
precisely
with
high
efficiency
and
rare
off-target
events
shows
promising
therapeutic
value
in
treating
hereditary
diseases.
Retinitis
pigmentosa
(RP)
the
most
common
type
of
inherited
retinal
dystrophy
characterized
by
progressive
degeneration
photoreceptors
and,
consequently,
visual
decline.
To
date,
effective
treatments
for
RP
are
lacking.
Herein,
a
PE
system
designed
to
target
PDE6B
Y347X
mutation
rd1
mouse
strain,
preclinical
model.
We
screen
develop
epegRNA
RTΔRnH,
which
delivered
via
dual-AAV
vivo
an
26.47
±
13.35%,
negligible
effects
confirmed
AID-Seq
PE-tag.
Treatment
greatly
restores
protein
expression
protects
rod
cells
from
degeneration.
Mouse
behavioural
experiments
also
show
that
compared
no
treatment,
inhibits
vision
deterioration
littermate
mice.
This
study
provides
opportunity
use
correct
mutated
RPs
genomic
level.
without
treatments.
Here,
authors
apply
(PE)
In
treatment
achieves
genome
mice
vision.
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Март 28, 2024
Abstract
Purpose
To
quantify
relevant
fundus
autofluorescence
(FAF)
image
features
cross-sectionally
and
longitudinally
in
a
large
cohort
of
inherited
retinal
diseases
(IRDs)
patients.
Design
Retrospective
study
imaging
data
(55-degree
blue-FAF
on
Heidelberg
Spectralis)
from
Participants
Patients
with
clinical
molecularly
confirmed
diagnosis
IRD
who
have
undergone
FAF
55-degree
at
Moorfields
Eye
Hospital
(MEH)
the
Royal
Liverpool
(RLH)
between
2004
2019.
Methods
Five
interest
were
defined:
vessels,
optic
disc,
perimacular
ring
increased
signal
(ring),
relative
hypo-autofluorescence
(hypo-AF)
hyper-autofluorescence
(hyper-AF).
Features
manually
annotated
by
six
graders
subset
patients
based
defined
grading
protocol
to
produce
segmentation
masks
train
an
AI
model,
AIRDetect,
which
was
then
applied
entire
MEH
dataset.
Main
Outcome
Measures
Quantitative
including
area
mm
2
vessel
metrics,
analysed
gene
age,
determine
rate
progression.
AIRDetect
feature
detection
validated
Dice
score
precision/recall,
respectively.
Results
A
total
45,749
images
3,606
covering
170
genes
automatically
segmented
using
AIRDetect.
Model-grader
scores
for
hypo-AF,
hyper-AF,
vessels
respectively
0.86,
0.72,
0.69,
0.68
0.65.
The
five
largest
hypo-AF
areas
CHM
,
ABCC6
ABCA4
RDH12
RPE65
mean
per-patient
41.5,
30.0,
21.9,
21.4,
15.1
.
hyper-AF
BEST1
CDH23
MYO7A
NR2E3
0.49,
0.45,
0.44,
0.39,
0.34
CRX
EYS
MYO7A,
3.63,
3.32,
2.84,
2.39,
2.16
Vessel
density
found
be
highest
EFEMP1
TIMP3
RS1
PRPH2
(10.6%,
10.3%,
9.8%,
9.7%,
8.9%)
lower
Retinitis
Pigmentosa
(RP)
Leber
Congenital
Amaurosis
genes.
Longitudinal
analysis
decreasing
four
RP
(
RPGR,
USH2A,
RHO,
)
fastest
progressor
-0.18
/year.
Conclusions
We
conducted
first
large-scale
cross-sectional
longitudinal
quantitative
across
diverse
range
IRDs
novel
approach.
Journal of Clinical Medicine,
Год журнала:
2024,
Номер
13(7), С. 2079 - 2079
Опубликована: Апрель 3, 2024
Inherited
retinal
diseases
(IRDs)
represent
one
of
the
major
causes
progressive
and
irreversible
vision
loss
in
working-age
population.
Over
last
few
decades,
advances
imaging
have
allowed
for
an
improvement
phenotypic
characterization
this
group
facilitated
phenotype-to-genotype
correlation
studies.
As
a
result,
number
clinical
trials
targeting
IRDs
has
steadily
increased,
commensurate
to
this,
need
novel
reproducible
outcome
measures
endpoints
grown.
This
review
aims
summarize
describe
presentation,
characteristic
findings,
endpoint
that
are
being
used
research
on
IRDs.
For
purpose
review,
been
divided
into
four
categories:
(1)
panretinal
pigmentary
retinopathies
affecting
rods
or
cones;
(2)
macular
dystrophies;
(3)
stationary
conditions;
(4)
hereditary
vitreoretinopathies.